The receptor tyrosine kinase Tie-1 is expressed predominantly on endothelia
l cells where it has an essential role in blood vessel formation. Targeted
disruption of the Tie-1 gene results in a lethal phenotype with severe disr
uption to the normal integrity of the vasculature. In an examination of Tie
-1 in vivo, we observed a significant pool of the receptor present in the c
irculation associated with the platelet fraction. Western blotting reveals
the platelet form of Tie-1 to be a protein of approximately 110 kDa, this c
ontrasts with the 135/125-kDa doublet found in endothelial cells. Platelet
activation results in increased surface expression of Tie-1. The closely re
lated receptor tyrosine kinase Tie-2/Tek is not present in platelets. Endot
helial Tie-1 undergoes metalloprotease-mediated ectodomain cleavage in resp
onse to phorbol ester and other agonists. Tie-1 cleavage leads to release o
f the extracellular domain and generation of a cell-associated intracellula
r domain with signalling capacity. The potential for cleavage was investiga
ted in platelets. In contrast to endothelial Tie-1, phorbol ester does not
stimulate truncation of the platelet receptor, suggesting these cells lack
one or more components of the regulated metalloprotease system controlling
Tie-1. These data demonstrate the Tie-1 receptor tyrosine kinase is present
on platelets and its surface expression is regulated. Furthermore, platele
t Tie-1 differs significantly from the endothelial receptor. Platelet Tie-1
has the potential to modulate endothelial function by competing for any Ti
e ligands and may have signalling roles important in controlling aspects of
platelet behaviour. Copyright (C) 2000 S. Karger AG. Basel.